Performa Ltd (US)’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.4K | Buy |
22,990
+5,740
| +33% | +$13.8K | 0.02% | 19 |
|
|
2025
Q1 | $38.1K | Buy |
17,250
+12,250
| +245% | +$27.1K | 0.01% | 20 |
|
|
2024
Q4 | $27.3K | Buy |
5,000
+4,300
| +614% | +$23.4K | 0.01% | 23 |
|
|
2024
Q3 | $5.82K | Buy |
700
+450
| +180% | +$3.74K | ﹤0.01% | 32 |
|
|
2024
Q2 | $1.79K | Sell |
250
-6,500
| -96% | -$46.5K | ﹤0.01% | 45 |
|
|
2024
Q1 | $58.5K | Buy |
6,750
+750
| +13% | +$6.5K | 0.03% | 21 |
|
|
2023
Q4 | $39.3K | Buy |
6,000
+3,175
| +112% | +$20.8K | 0.02% | 23 |
|
|
2023
Q3 | $28.3K | Buy |
2,825
+825
| +41% | +$8.25K | 0.01% | 24 |
|
|
2023
Q2 | $24.9K | Buy |
2,000
+200
| +11% | +$2.49K | 0.01% | 26 |
|
|
2023
Q1 | $25.2K | Buy |
1,800
+300
| +20% | +$4.2K | 0.01% | 26 |
|
|
2022
Q4 | $21.5K | Buy |
1,500
+1,250
| +500% | +$17.9K | 0.01% | 28 |
|
|
2022
Q3 | $6K | Buy |
250
+200
| +400% | +$4.8K | ﹤0.01% | 44 |
|
|
2022
Q2 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 61 |
|